These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3025928)

  • 1. Design and interpretation of opiate antagonist trials in dementia.
    Tariot PN; Sunderland T; Murphy DL; Cohen MR; Welkowitz JA; Weingartner H; Newhouse PA; Cohen RM
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):611-26. PubMed ID: 3025928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Arch Gen Psychiatry; 1986 Aug; 43(8):727-32. PubMed ID: 3729666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose naloxone in older normal subjects: implications for Alzheimer's disease.
    Tariot PN; Gross M; Sunderland T; Cohen MR; Weingartner H; Murphy DL; Cohen RM
    J Am Geriatr Soc; 1988 Aug; 36(8):681-6. PubMed ID: 3042841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous and endogenous opioid-induced enhancements of naloxone's effects on serum luteinizing hormone levels in the male rat.
    Cicero TJ; Owens DP; Newman KS; Schmoeker PF; Meyer ER
    Eur J Pharmacol; 1984 Oct; 105(3-4):273-84. PubMed ID: 6096156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses.
    Cohen MR; Cohen RM; Pickar D; Weingartner H; Murphy DL
    Arch Gen Psychiatry; 1983 Jun; 40(6):613-9. PubMed ID: 6303264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of naloxone sensitivity in obese humans.
    O'Brien CP; Stunkard AJ; Ternes JW
    Psychosom Med; 1982 May; 44(2):215-23. PubMed ID: 6283579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological challenges to the endogenous opioid system in affective illness.
    Cohen MR; Pickar D
    J Clin Psychopharmacol; 1981 Jul; 1(4):223-31. PubMed ID: 7028803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
    Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
    Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental endotoxin shock: the pathophysiologic function of endorphins and treatment with opiate antagonists.
    Faden AI; Holaday JW
    J Infect Dis; 1980 Aug; 142(2):229-38. PubMed ID: 6251139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of naloxone in the identification of pain control mechanisms operated by endogenous opioids.
    Hill RG
    Neurosci Lett; 1981 Jan; 21(2):217-22. PubMed ID: 6261192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opiates and nociception: a possible functional role in both pain inhibition and detection as revealed by intrathecal naloxone.
    Dickenson AH; Le Bars D; Besson JM
    Neurosci Lett; 1981 Jul; 24(2):161-4. PubMed ID: 7254713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opiate systems and primate reproduction: inability of naloxone to induce sexual activity in rhesus males.
    Glick BB; Baughman WL; Jensen JN; Phoenix CH
    Arch Sex Behav; 1982 Jun; 11(3):267-75. PubMed ID: 6890336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadectomy influences the inhibitory effect of the endogenous opiate system on pulsatile gonadotropin secretion.
    Masotto C; Negro-Vilar A
    Endocrinology; 1988 Aug; 123(2):747-52. PubMed ID: 2840268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate antagonist in traumatic shock.
    McIntosh TK; Faden AI
    Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesia produced by low doses of the opiate antagonist naloxone in arthritic rats is reduced in morphine-tolerant animals.
    Kayser V; Besson JM; Guilbaud G
    Brain Res; 1986 Apr; 371(1):37-41. PubMed ID: 3011202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence.
    Krishnan-Sarin S; Rosen MI; O'Malley SS
    Arch Gen Psychiatry; 1999 Jul; 56(7):663-8. PubMed ID: 10401515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation.
    Gold MS; Redmond DE; Donabedian RK
    Endocrinology; 1979 Jul; 105(1):284-9. PubMed ID: 221205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides and seizures.
    Snead OC
    Neurol Clin; 1986 Nov; 4(4):863-75. PubMed ID: 3025583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological effects of high dose naloxone administration to normal adults.
    Cohen MR; Cohen RM; Pickar D; Murphy DL; Bunney WE
    Life Sci; 1982 Jun; 30(23):2025-31. PubMed ID: 6287138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.